yoga therapy for myalgic encephalomyelis/ chronic fague … · 2018. 10. 28. · 2018/10/17 8th...
TRANSCRIPT
2018/10/178thIASPSymposiumonYogaResearch,Kripalu
Yogatherapyformyalgicencephalomyeli2s/chronicfa2guesyndrome(ME/CFS):
Effec2venessanduderlyingmechanisms
TakakazuOka,M.D.,Ph.D.
DepartmentofPsychosoma1cMedicine,GraduateSchoolofMedicalSciences,
Interna1onalUniversityofHealthandWelfare,Japan
Outline
• Whatismyalgicencephalomyeli2s/
chronicfa2guesyndrome(ME/CFS)?
• IsometricyogaforME/CFS
• Resultsofrecentstudies
TakakazuOkaof30yearsago �
Youmustknowhim. �
CarruthersBM,etal:JInternMed2011,270:327-338.
ME/CFS:Interna2onalConsensusCriteria
(A) Post-exer2onalneuroimmuneexhaus2on(malaise):• Marked,rapidphysicaland⁄orcogniOvefaOgueinresponsetoexerOon• ExacerbaOon/exhausOonofpost-exerOonsymptoms
(B)Neurologicalimpairments• NeurocogniOveimpairments
• DifficultyprocessinginformaOon(slowedthoughts,impaired concentraOon)
• Short-termmemoryloss(difficultyremembering)• Pain(headache,widespreadpain)• Sleepdisturbance(unrefreshingsleep)
(C)Immune,gastro-intes2nalandgenitourinaryimpairments• Flu-likesymptoms
(D)Energyproduc2on⁄transportimpairments:• OrthostaOcintolerance,thermoregulatoryinstability
Comorbidi2es• fibromyalgia,irritablebowelsyndrome,reacOvedepression
TGF-β↑,Proinflamm.cytokines(TNF-α)↑NKcellacOvity↓Th2-predominant,
AutoanObody,Treg↑BcelldysfuncOon
ImmuneEndocrine
DLPFCfuncOon↓,reducedvolumeReducedACCand
basalgangliafuncOonMicroglialacOvaOon
CNS
HPAaxisdysfuncOoncorOsol↓
(bluntedawakeningresponse)DHEA-S↓
Intes2nalflora
Psychologicalstress
ParasympatheOcn.↓(RelaOvesympatheOc
predominancy)
ANS
Smallheart,tachycardia,CO↓,SV↓RAA�system↓
ADHsystem↓
PosturalorthostaOctachycardia
GlycolyOcandTCAcycledysfuncOon
Energy/metabolismCardiovascular
Comorbiddiseases
Oxida2vestress
Treatment(basedonCanadianConsensusDocument)
1) Self-helpstrategies,Pacing• AssistspaOentsincopingwiththeirchronicillnessbyconservingenergy,minimizingsymptomflare-ups,andmaximizingcopingskillsandfuncOonality
• Bodymovementandfitness:EncouragepaOentstousegoodbodymechanicsaswellastechniquesandpracOces,suchasyoga,toimprovebalance
2) Self-poweredexercise• TradiOonalexerciseprogramscanprovokediseaserelapse• Exercisemustbeindividualized,undertakenwithcauOon,and diligentlymonitored
3) Symptommanagementandtreatment• Physicalremedies• Pharmacotherapy
AClinicalCaseDefiniOonandGuidelinesforMedicalPracOOoners,2005
Whattypesofyoga?
Yogahasbeenreportedtoimprovefa2gueinmanyclinicalpopula2onssuchascancerpa2ents.However,pa2entswithME/CFScan’tprac2cemanykindsoftradi2onalyogaposes.Iconsultedyogatherapistsanddevelopedaprogramthatconsidersdiseasepathophysiologyandpa2entlimits
ME/CFSpa2entshave:• Severefa2gueandpost-exer2onalmalaise
• PracOcingyogashouldnotexacerbatesymptoms,especiallypostexerOonalmalaise
• Decondi2oning• Yogashouldactasexercisetherapy
• Impairedconcentra2onandmemory• Theprogramshouldbesimpleandeasytoperform
• Orthosta2cintolerance• Nostandingposturesshouldbeperformed
• Soundandlightsensi2vity• YogainstrucOonshouldnotinvolveamicrophoneormusicandclassesshouldbeheldinadimly-litroom
Whatwasconsidered?
Weacceptedseatedisometricyoga
Benefitsofisometricyoga:1) ResistancecanbeadjustedrelaOvetothepaOent’scondiOonto
avoidexacerbaOonoffaOgueandpost-exerOonmalaise2) Norequirementforstrongstretchesandphysicalflexibility-
prevenOonofoverstretchingthatcanincreasepain3)Post-isometricrelaxa2onthatinducesmuscular(andalso
psychological)relaxaOonandincreasesmuscularstrengthSeatedIsometricYogaissimilartotradi2onalyoga:PosesareconductedslowlyinaccordancewithbreathingandwithawarenessofinnersensaOons(propriocepOon)
SeatedisometricyogaforME/CFSpa2ents(20min)
position. Electrodes were placed on both wrists. Beat-to-beat HR was assessed on the ECG, and HRV indices andrespiratory rate were measured using the “Kiritsu Meijin”(Crosswell Co., Inc., Yokohama, Japan) [33], which in-cluded a HR monitor LRR-03 (GMS, Tokyo, Japan). Themajority of previous studies have used spectral techniquesbased on the Fast Fourier Transform (FFT). However, FFTis insufficient to estimate the precise power spectral dens-ity from short time series data. The MemCalc method[34] is a new technique for time series analysis. It is acombination of the maximum entropy method for spectralanalysis and the non-linear least squares method for fit-ting analysis. This enabled us to achieve a reliable analysisof the low- (LF; 0.05–0.15 Hz) and high-frequency com-ponents (HF; 0.15–0.4 Hz) over a minimum interval of30 s. Time domain analysis and spectral analyses of HRvariability using the MemCalc system were performedover a 1-min period. In the time domain analysis, thecoefficient of variation of R-R intervals (CVR-R) =component coefficient of variance (total power) wasshown. HF was used as an index of parasympatheticactivity, while LF was used as a mixed index of sym-pathetic and parasympathetic activity. LF/ HF wasused as an index of sympathetic activity [34–36].
Blood biomarkersSerum markersSerum levels of DHEA-S were measured using achemiluminescent enzyme immunoassay (CLEIA).Cortisol and prolactin (PRL) were measured byelectro-chemiluminescence immunoassay. Total carnitine,
acylcarnitine, and free carnitine were measured bythe enzyme cycling method. IL-6 was measuredusing a human IL-6 CLEIA cartridge (Fujirebio,Tokyo, Japan), with a minimum detectable concen-tration of 0.2 pg/mL. TNF-α was measured byenzyme-linked immunosorbent assay (ELISA) usingQuantikine high-sensitivity ELISA human TNF-α im-munoassay (R&D Systems, Inc., Minneapolis, MN,USA), with a minimum detectable concentration of0.07 pg/mL. IFN-α was measured using the Veri-Kine™ Human Interferon Alpha Multi-Subtype SerumELISA Kit (pbl assay science, Piscataway, NJ, USA),with a minimum detectable concentration of 12.5 pg/mL.IFN-γ was measured by enzyme amplified sensitivityimmunoassay (EASIA) using the MEDGENIX humanIFN-γ EASIA kit (BioSource Europe S.A., Nivelles,Belgium), with a minimum detectable concentrationof 0.1 IU/mL.
Plasma makersPlasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG)and homovanillic acid (HVA) were measured by highperformance liquid chromatography. Brain-derivedneurotrophic factor (BDNF) was measured using theQuantikine ELISA human BDNF kit (R&D Systems,Inc., Minneapolis, MN, USA), with a minimumdetectable concentration of 20 pg/mL. TGF-β1 wasassessed using the Quantikine ELISA human TGF-β1kit (R&D Systems, Inc., Minneapolis, MN, USA), witha minimum detectable concentration of 0.50 pg/mL.
Fig. 2 Sitting isometric yoga program. The 20-min sitting isometric yoga program consisted of three parts. (1) Patients practiced being aware oftheir spontaneous breathing for 1 min to facilitate interoceptive and proprioceptive awareness. (2) Patients slowly practiced six isometric postures,taking 3–10 s each (5 s in average), in association with exhalation with/without sounds, using 50% maximal physical strength. (3) Patients practicedabdominal breathing for 1 min
Oka et al. BioPsychoSocial Medicine (2018) 12:3 Page 4 of 11
Beawareofspontaneousbreathingfor1min.
(2)Sixisometricposes(performed4-6Omeseach)SlowmovementssynchronizedwithbreathingIsometricexerciseat50%ofmaximalphysicalstrengthSlowlyrelaxandreturntothebasalposiOon
Abdominalbreathingfor1min.
Study1Short-andlong-termeffectsofseatedisometricyogaforME/CFSpa2ents:arandomizedcontrolledtrial
Excluded
SaOsfactoryimprovement(n=35)<20years-old(n=12)
Diseasetoosevere(n=2)DeclinedtoparOcipate(n=2)
CompletedtheintervenOon(n=15)
CompletedtheintervenOon(n=15)
RandomizaOon(n=30)
Analysis
Yoga+TAUgroup(n=15)
TAU(control)group(n=15)
AllocaOon
Assessedforeligibility(n=81)
Inclusioncriteria(1)Lackofsufficientimprovementdespiteatleast6monthsofconvenOonaltherapy(2)Between20and70years-old(3)FaOguelevelthatdoesnotrequireassistance(4)AbletocompletequesOonnairewithoutassistance(5)Abletositforatleast30minutes(6)Abletovisithospitalregularly
TAU:treatmentasusual
IntervenOon:TAUwith/without20-minyogafor8weeks
5101520253035
F V
PrePost
**
10
15
20
25
30
35
pre post
Yoga
Control
Totalscore
**
#
***
Long-termeffects(preintervenOon-8weeks)
Chalderfa2guescale
Short-termeffects(pre-andpost-20minyoga
withayogatherapist-valuesforweek8)
MoodstatusprofileF(faOgue) V(vigor)
***p<0.001.**p<0.01.(pairedt-test) **p<0.01(pairedt-test)#p<0.05(independent-samplet-test)
Totalscore
OkaTetal.,BiopsychosocMed2014,8,27
TAU
Yoga+TAU
Seatedisometricyogaprogramdecreasesfa2gueandimprovesmoodstatusprofile
Short-termeffectsofseatedisometricyogaprogramonautonomicparameters
Resultssuggestac2va2onofparasympathe2cnervousfunc2on
Parameter Pre Post Pvalue
HR(bpm) 84.5±9.3 80.0±6.3 0.047
HF(ms2) 103.7±88.6 168.1±138.8 0.028
LF(ms2) 365.0±676.6 268.3±223.8 n.s.
LF/HF 5.4±8.3 2.2±1.3 n.s.
CVR-R(%) 3.4±1.5 3.4±1.2 n.s.
HF:HighfrequencyLF:LowfrequencyLF/HF:raOolowtohighfrequencyCVR-R:CoefficientofvarianceofR-Rintervalsofheartratevariabilityn.s.:notsignificant
OkaTetal,BiopsychosocMed2018,12,3
Short-termeffectsofseatedisometricyogaprogramonbloodbiomarkers
Parameter Pre Post Pvalue
Cor2sol(µg/dL) 11.0±6.4 7.9±3.5 0.016
DHEA-S(µg/dL) 177.7±63.3 191.1±73.5 0.012
TNF-α(pg/mL) 0.9±0.18 0.8±0.18 0.035
IL-6(pg/mL) 1.2±0.6 1.3±0.5 n.s.
Prolac2n(ng/mL) 11.1±6.3 9.9±5.7 0.08
TotalCarniOne(µmol/L) 52.6±12.4 52.3±12.4 n.s.
TGF-β1(ng/mL) 10.0±8.5 11.2±7.5 n.s.
BDNF(pg/mL) 4237±4522.3 5295±4489.7 n.s.
MHPG(ng/mL) 3.7±1.3 3.8±1.4 n.s.
HVA(ng/mL) 10.9±9.4 10.9±9.3 n.s.
*DopamineactsasprolacOninhibitoryhormone.
-20
-15
-10
-5
0
-20 -10 0 10
r=0.555P=0.049
∆TGF-β1(µmol/L)
∆F(faO
gue)sc
ore
OkaTetal,BiopsychosocMed2018,12,3
-5
0
5
10
15
-5 0 5 10
r=0.573P=0.026
∆V(vigor)score
∆HVA(ng/mL)
←FaO
gueredu
ced
Energyincreased
→
Correla2onbetweenfa2gueandTGF-β1levelandbetweenvigorandHVAlevelsfollowingseatedisometricyogaprogram
HVA(homovanillicacid):anindicatorofDAfuncOon
SF-8Parameter Pre Post Pvalue
PhysicalfuncOoning(PF) 39.6±9.1 42.5±7.1 n.s.
Physicalrole(PR) 34.4±8.4 38.4±6.4 n.s.
Bodilypain(BP) 41.3±6.7 48.1±7.9 P=0.0001
Generalhealthpercep2on(GH) 39.3±5.3 43.6±6.0 P=0.0021
Vitality(VT) 43.7±4.9 43.5±6.1 n.s.
SocialfuncOoning(SF) 37.6±7.8 37.6±7.8 n.s.
EmoOonalrole(ER) 39.2±12.6 44.4±9.3 n.s.
Mentalhealth(MH) 45.8±9.5 46.8±9.5 n.s.
Physicalcomponentsummary(PCS) 35.8±7.2 40.6±4.7 P=0.024
Mentalcomponentsummary(MCS) 44.1±8.5 44.5±7.9 n.s.
Seatedisometricyogaprogramimprovesqualityoflifebyreducingpainandimprovinggeneralhealthpercep2on
OkaTetal.,BiopsychosocMed2018,12,3
Longtermeffect,prevspost(2months)
YogaDiary
• AllstudysubjectsreportedthattheirbodiesfeltwarmerandlighteraverpracOcingseatedisometricyoga
• StudysubjectsreportedreducedfaOgueandpain
• Studysubjectstatements:• “Iwokeupmoreeasilythemorning
averpracOcingyoga.”• “MymindbecamemorecalmandI
feltworry-free.”
Long-termeffectseffectsofseatedisometricyogaprogram
Parameter Pre Post Pvalue
HR(bpm) 88.1±8.5 85±9.5 n.s.
HF(ms2) 74.7±79.4 70.4±62.3 n.s.
LF(ms2) 163.4±197.1 204.9±363.9 n.s.
LF/HF 4.5±5.4 4.8±7.1 n.s.
CVR-R(%) 3.5±1.6 3.5±1.5 n.s.
Parameter Pre Post Pvalue
HADS-Depression 8.3±4.6 5.7±5.4 0.02
HADS-Anxiety 7.7±4.8 6.9±4 n.s.
Autonomicparameters
Psychologicalparameters
Parameter Pre Post Pvalue
CorOsol(µg/dL) 11.5±8.3 10.4±6.3 n.s.
DHEA-S(µg/dL) 178.4±67.7 180.5±66.5 n.s.
TNF-α(pg/mL) 0.9±0.2 0.8±0.2 n.s.
IL-6(pg/mL) 1.1±0.6 1.2±0.6 n.s.
Prolac2n(ng/mL) 11.4±6.3 11.1±6.3 0.08
T-Carn(µmol/L) 53±12.5 52.6±12.4 n.s.
TGF-β1(ng/mL) 13.1±16.2 10±8.5 n.s.
BDNF(ng/mL) 5.8±8.2 4.2±4.5 n.s.
MHPG(ng/mL) 3.6±1.1 3.7±1.3 n.s.
HVA(ng/mL) 9.1±3.7 10.9±9.4 n.s.*DopamineactsasprolacOninhibitoryhormone
Long-termeffectsofseatedisometricyogaprogramonbloodbiomarkerlevels
∆Ch
alde
rFaO
gueScalescore
∆TNF-α(pg/mL)
Long-termeffectsofseatedisometricyogaprogramonChalderFa2gueScoreasafunc2onofTNF-α concentra2on
-25
-20
-15
-10
-5
0
5
-1 -0.5 0 0.5
←FaO
gueredu
ced
Study2Effectsofrecumbentisometricyogaonpa2entswithsevereME/CFS:arandomizedcontrolledtrial
Problemstobesolved1)Todevelopyogaprogramforseverepa2ents 2)Toanalyzefurtheronthemechanismsoflong-termeffectofisometricyoga
(1a)
(3a)
(1b)
(2a) (2b) (2c)
(2d) (2e)
(3c)(3b)
Developmentofa20-minrecumbentisometricyogaprogramforpa2entswithsevereME/CFS
CompletedtheintervenOon(n=24)
CompletedtheintervenOon(n=24)
RandomizaOon(n=50)
Analysis
Yoga+TAUgroup(n=25)
TAU(control)group(n=25)
AllocaOon
Assessedforeligibility(n=358)
Subgroup Yoga+TAU TAU
Severe(PS7-8) 14 13
Mildtomoderate(PS3-6) 10 11
Withfibromyalgia 6 7
PS:performancestatus(indexofseverityandimpairedfuncOon)
IntervenOon:TAUwith/without20-minrecumbentisometricyogafor12weeks
10
15
20
25
30
pre post
Yoga+TAU
TAU
**
#
**p<0.01(pairedt-test)#p<0.05(independent-samplet-test)
**
Chalde
rFaO
guescalescore
Long-termeffectsofrecumbentisometricyoga(preintervenOon-12weeks)
(n=24)
Long-termeffectsofrecumbentisometricyoga(preintervenOon-12weeks)
Classifica2on Pre Post pSevere(n=14) 26.3±4.7 19.2±5.9 P<0.0001Moderate(n=10) 19.3±4.3 16.4±5.7 P=0.1WithFM(n=6) 30.2±2.3 23.8±4.8 P=0.008
Classifica2on Pre Post p
HADSAnxiety 8.2±4.2 5.7±3.6 P=0.007
HADSDepression 10.2±3.9 7.5±3.7 P=0.0003
ChalderFaOgueScalescore
Psychologicalparameters
FM:fibromyalgia
Significanceoftheprefrontalcortex(PFC)inME/CFS
• Gray-ma{erinthebilateralPFCisreducedinME/CFSpaOents
• ThevolumereducOoninthertPFCwasassociatedwithfa2gueseverity
OkadaTetal.,BMCNeurology2004,4:14
Within-group analysis of regional changes in grey mattervolume between the pre- and post-CBT scans revealedsignificant regional increases bilaterally in the inferiorfrontal gyrus [left IFG: (–36, 39, 17), t(21) = 5.49,PFWE = 0.010, PFDR = 0.025; right IFG: (39, 35, 23),t(21) = 5.49, PFWE = 0.005, PFDR = 0.011] for the CFS group(Fig. 3), but no changes for the healthy controls. Both these
clusters were located at the most dorsal portion of theinferior frontal gyrus and in the depth of the middle frontalsulcus, within the borders of cyto-architectonicallydefined Brodmann area 46/9 (Rajkowska and Goldman-Rakic, 1995).
In terms of cognitive speed, CFS patients became fasteron the CRT (t21 = 2.30, P= 0.032), while they did not show
Table 2 Baseline and follow-up physical and cognitiveperformance of participants
Baseline Follow-up Difference
CFS patientsFunctional statusCIS fatigue (8^56)a 48.4(1.3) 29.3 (2.9) !19.0 (2.9)"""
SIP total (0^9937)a 1334 (124) 550 (115) !784 (128)"""
Physical activityMean actometer score 63.5 (4.6) 73.2 (3.5) +9.7 (4.8)"
Pervasively passive (%) 32 9 !23Relatively active (%) 68 91 +23
Cognitive speedWAIS-dst 60.2 (2.8) 62.5 (2.9) 2.3 (1.6)NS
CRT (ms) 348 (14.2) 329 (11.5) !19.4 (8.4)""
SRT (ms) 307 (11.6) 297 (12.8) !10.3 (9.6)NS
Cerebral volumeGrey matter (ml) 669.4 (14.4) 674.1 (15.1) +4.7 (2.3)""
White matter (ml) 406.1 (8.9) 404.7 (8.9) !1.4 (1.0)NS
Healthy controlsFunctional statusCIS fatigue (8^56)a 21.2 (2.4) 18.7 (2.1) !2.5 (2.7)NS
SIP total (0^9937)a 131 (63) 169 (69) +38 (36)NS
Cerebral volumeGrey matter (ml) 708.2 (12.0) 708.0 (12.6) !0.2 (1.7)NS
White matter (ml) 423.2 (9.0) 421.4 (8.7) !1.8 (1.7)NS
Values are given as means (SE).aRange of the scale.NS=Not significant. "p50.1. ""p50.05."""p50.001.
Fig. 2 Effect of CBTon grey matter volume. (A) There is a significant increase in GMV between baseline and follow-up in CFS patients, butnot in healthy control subjects. (B) There is a negative correlation between the increase in GMV following CBTand the patient’s age.
Fig. 3 Anatomical localization of grey matter volume increase.Results are superimposed on the average normalized brain of allCFS patients. There is a significant increase in prefrontal greymatter volume (BA 46/9) as a result of CBT in CFS patients.(A) sagittal view. (B) Coronal view. (C) Axial view. Results aredisplayed at P50.001 uncorrected, for display purposes.
2176 Brain (2008), 131, 2172^2180 F. P. de Lange et al.
at (D) K
yushu U R
igakubu on August 31, 2012
http://brain.oxfordjournals.org/D
ownloaded from
CogniOvebehavioraltherapyincreasedgrayma{ervolumeinthelateralPFCinME/CFSpaOents.deLangeFP,etal.Brain2008,131:2172-2180.
High-frequencyrTMSdeliveredtotheltDLPFCreducedfa2gueinME/CFSpaOents.KakudaWetal.,InternMed2016,55:3515-3519.
<結果> #症状への影響は、患者各人で異なっていた。しかしながら、総じて、患者 7人中 6人でなんらかの症状の改善、特に生活状況の改善が確認された。
#例えば、「屋外を長時間歩くことができるようになった」、「人の力をかりずに、入浴や洗髪がで
きるようになった」、「長時間続けて本を読むことができるようになった」、「長時間デスクワーク
にとりくむことができた」、「数年ぶりに集中力が高まる感じを自覚した」などと患者は述べた。 #症状をスコア(点数)でも評価したが、TMS治療によってこの点数は、統計学的に有意な改善を示した。たとえば、退院の時点で約 40%の改善が、退院後 2週間の時点で約 30%の改善が、確認された。
#退院後 2週間の時点までの経過観察では、やや効果の減弱が示唆されたものの、およそは退院後も症状の改善が持続していた。
#2人の患者では、入院中に一時的に不快感もしくは立ちくらみがみられたが、いずれも特に治療を要することなく回復した。その他、特記すべき有害事象はいずれの患者においてもなかった。
*対象患者 7人の平均 値をあらわす。
TGF-β↑,Proinflamm.Cytokines(TNF-α)↑NKcellacOvity↓Th2-predominant,
AutoanObody,Treg↑BcelldysfuncOon
ImmuneEndocrine
DLPFCfuncOon↓,reducedvolumeReducedACCand
basalgangliafuncOonMicroglialacOvaOon
CNS
HPAaxisdysfuncOoncorOsol↓
(bluntedawakeningresponse)DHEA-S↓
Intes2nalflora
Psychologicalstress
ParasympatheOcn.↓(RelaOvesympatheOc
predominancy)
ANS
Smallheart,tachycardia,CO↓,SV↓RAA�system↓
ADHsystem↓
PosturalorthostaOctachycardia
GlycolyOcandTCAcycledysfuncOon
Energy/metabolismCardiovascular
Comorbiddiseases
Oxida2vestress
2018/10/02 15(20Isometric yoga program for ME CFS - YouTube
5 / 5 ページhttps://www.youtube.com/watch?v=tuQngCHfrvk&t=256s
Laura Stanley 6 か月前Dr. Takakazu, I am deeply grateful to you for this excellent video and program. I am seriously ill with ME/CFS, and this is the only exercise I can do at this time. As long as I follow your instruction to not use all my strength, it really helps me to feel more balanced and energized. I have begun sharing it with fellow patients in my support groups, and they have been enthusiastic. We hope you will be able to produce additional programs for us someday! Thank you, thank you!
Sophie 7 か月前Thank you so much for making this available. I haven't been doing it for long enough to feel any signiScant changes, but so far I haven't felt any extra fatigue/pain the next day, which is amazing
Adrienne Wooding 11 か月前(編集済み)Helpful to some severe but not too severe MECFS patients but it is a shame that objective physiological markers weren't used to measure the effectiveness of the program. It would have been nice if the DePaul Questionaire (a symptom speciScally scale for people with ME/CFS) used as the disease is far more than fatigue.
返信
返信を表示
返信
返信を表示
返信
返信を表示
2018/10/02 15(27mecfs yoga - YouTube
2 / 4 ページhttps://www.youtube.com/results?search_query=mecfs+yoga
Oka Takakazu岡 孝和チャンネル登録者数 77 人 • 3 本の動画
yogatherapy for ME CFS日本ヨーガ療法学会Yoga Therapy Society Japan •3066 回視聴 • 1 年前yoga for ME CFS.
Easy Quick Yoga For CFS/M.E.Yoga, Mybed & M.E • 659 回視聴 • 8 か月前A very short yoga routine to keep mobility and stiffness at baywhile working lymph and circulation whilst suffering from CFS/ME.
ME/CFS: Katherine's Story of Recoveryfrom Chronic Illness Through YogaME/CFS Community • 1218 回視聴 • 4 年前Katherine's recovery from chronic illness has been a journey ofovercoming pain and suffering. Her's is also a journey of ...
Bed table yoga for M.E / CFSYoga, Mybed & M.E • 431 回視聴 • 1 年前How to use a bed / laptop table within your yoga practice to helpsupport and aid you into gentle poses. Caution: brain fog in ...
Yoga for M.E. my personal nighttime yogaroutineYoga, Mybed & M.E • 1708 回視聴 • 1 年前This is my nighttime yoga for M.E. CFS on a good health day.
Dr.Takakazu,Iamdeeplygratefultoyouforthisexcellentvideoandprogram.IamseriouslyillwithME/CFS,andthisistheonlyexerciseIcandoatthisOme.AslongasIfollowyourinstruc2ontonotuseallmystrength,itreallyhelpsmetofeelmorebalancedandenergized.…………….Thankyou,thankyou!�
ViewdemonstraOonsofisometricyogaprogramsonYouTube
Conclusions
��
• Isometricyogaisbeneficialasaself-helpstrategyoradjuncttherapyforME/CFS
• MulOplefactorsmaycontributetothebeneficialeffectsofisometricyoga:• AnO-depressiveandanxiolyOceffects• AnO-stressandanO-inflammatoryeffects
• TherapeuOcyogaprogramforspecificdiseasesshouldconsider:• WhethertradiOonalyogaisapplicableandeffecOve• DiseasepathophysiologyandpaOentlimitaOons
• CollaboraOonbetweenmedicalspecialistsandyogaspecialistsiscrucialfordevelopingeffecOvetherapeuOcyogaprograms
2018/06/12 9)18Change the World - One article at a time | For Researchers | Springer Nature
1 / 8 ページhttps://www.springernature.com/gp/researchers/campaigns/chang…ail&sap-outbound-id=26C8272DC5F702AC8C87BD764F1C9F9439801F5E
Change the WorldRead groundbreaking scientific findings that could help humanityand protect our planet
Watch the video
Search2018/06/12 9)18Change the World - One article at a time | For Researchers | Springer Nature
8 / 8 ページhttps://www.springernature.com/gp/researchers/campaigns/chan…ail&sap-outbound-id=26C8272DC5F702AC8C87BD764F1C9F9439801F5E
© 2018 Springer Nature Legal notice General terms and conditions Privacy
FollowusonTwitter
FollowusonFacebook
ConnectonLinkedIn
WatchusonYouTube
FollowusonInstagram
Stay up to date
SpringerNatureChangetheWorldIni2a2vein2018,ChangestheWorld,MedicineandPublicHealthAr2cles �
2018/06/12 9)04Change the World - Medicine and Public Health | For Researchers | Springer Nature
7 / 19 ページhttps://www.springernature.com/gp/researchers/campaigns/chan…ail&sap-outbound-id=26C8272DC5F702AC8C87BD764F1C9F9439801F5E
dcentral.com/articles/10.1186/s13030-017-0090-z?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_13)Biopsychosocial Medicine
Yoga for bedridden patients
might seem counterintuitive,
but this new style of yoga
can yield impressive benefits
for patients with severe
fatigue.
017-1559-2?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_14)BMC Pregnancy and
Childbirth
As pertussis is now a
growing threat, vaccination
for pregnant women has
become more common.
This study examines the
available evidence on the
efficacy and safety of this
approach and highlights
the need for further
research.
n_ctw2018_5_med_15)Neurotherapeutics
In this study, patients with
amyotrophic lateral sclerosis
(ALS) who received
dextromethorphan plus
quinidine reported improved
speech and swallowing.
Environmental pollutionwith antimicrobialagents from bulk drugmanufacturingindustries in Hyderabad,South India, isassociated withdissemination ofextended-spectrumbeta-lactamase andcarbapenemase-producing pathogens (https://link.springer.com/article/10.1007%2Fs15010-017-1007-2?&utm_medium=other&utm_source=other&utm_content=5022018&utm
Evidence-Based SocialCommunicationInterventions forChildren with AutismSpectrum Disorder (https://link.springer.com/article/10.1007%2Fs12098-015-1938-5?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_17)The Indian Journal of
Pediatrics
Guidance on interventions
for ASD.
Expert consensusdocument:Mitochondrial functionas a therapeutic targetin heart failure (https://www.nature.com/articles/nrcardio.2016.203?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_18)Nature Reviews Cardiology
This Consensus Statement
explores mitochondria as a
therapeutic target for heart
failure, a prevalent condition
2018/06/12 9)04Change the World - Medicine and Public Health | For Researchers | Springer Nature
6 / 19 ページhttps://www.springernature.com/gp/researchers/campaigns/chan…ail&sap-outbound-id=26C8272DC5F702AC8C87BD764F1C9F9439801F5E
Automated analysis offree speech predictspsychosis onset in high-risk youths (https://www.nature.com/articles/npjschz201530?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_10)npj Schizophrenia
People with schizophrenia
experience subtle speech
problems, even before they
first develop psychosis. A
computer program that
analyzes natural speech
could help predict the onset
of psychosis in young
people at risk.
Calretinin as a blood-based biomarker formesothelioma (https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3375-5?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_11)BMC Cancer
This study was featured in
over 50 news outlets. It
describes a new blood test
that could mean earlier
diagnosis for
mesothelioma:
https://survivingmesothelioma.com/a-
new-blood-test-for-
mesothelioma/
Chemical and non-chemical stressorsaffecting childhoodobesity: a systematicscoping review (https://www.nature.com/articles/jes201718?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_12)Journal of Exposure Science
and Environmental
Epidemiology
A critical review of how the
numerous chemical and
non-chemical stressors in a
child’s environment may
combine to affect his or her
health.
Development of arecumbent isometricyoga program forpatients with severechronic fatiguesyndrome/myalgicencephalomyelitis: Apilot study to assessfeasibility and efficacy. (https://bpsmedicine.biomedcentral.com/articles/10.1
Efficacy and safety ofpertussis vaccinationfor pregnant women –a systematic review ofrandomised controlledtrials andobservational studies (https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-017-1559-2?&utm_mediu
Enhanced BulbarFunction in AmyotrophicLateral Sclerosis: TheNuedexta TreatmentTrial (https://link.springer.com/article/10.1007/s13311-016-0508-5?&utm_medium=other&utm_source=other&utm_content=5022018&utm_campaign=10_dann_ctw2018_5_med_15)
2018/06/12 9)18Change the World - One article at a time | For Researchers | Springer Nature
3 / 8 ページhttps://www.springernature.com/gp/researchers/campaigns/chan…ail&sap-outbound-id=26C8272DC5F702AC8C87BD764F1C9F9439801F5E
Biomedicine and Life Sciences
Chemistry, Engineering, Physics,Materials
Earth and Environmental Sciences
Economics, Business, ComputerSciences, Statistics
Medicine and Public Health
Social Sciences, Education,Philosophy, Psychology
Explore more than250 nominatedarticles across allsubject areas
Grants
MinistryofHealth,LaborandWelfare(H24-Iryo-Ippan-025,H26-Iryo-Ippan-008)TheJapanAgencyforMedicalResearchandDevelopmentGrantforintegra2vemedicine(H2715lk0310013h0001,H2816lk0310017h001,H2917lk0310034h0001).
�
Acknowledgements
Interna1onalUniversityofHealthandWelfarePsychosoma1cMedicine
YuYamadaBa{uvshin Lkhagvasuren
TheJapanYogaTherapySociety
HisakoWakitaTakakoIshidaKeishinKimura
KyushuUniversityPsychosoma1cMedicine
TokuseiTanahashiKazuhumiYoshiharaShuTakakuraNobuyukiSudo